NCT Number: NCT06446648
Phase: EARLY_PHASE1
Trial Summary: This is a pilot, 3 phases open-label feasibility study with the 3rd phase consisting of randomized 2-arm intervention trial, to assess the systematic use of indocyanine green (ICG) in subjects with pr – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of California, Irvine
Acronym:
Relationship bw Image-deriv Features of Intraoperative ICG Visualiz of NVBs During RARP & Functional Outcome
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives